IPOs and Secondaries
IPOs and Secondaries Articles
Clearside Biomedical has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Depending on how you count these things, the month of March now has two or three initial public offerings (IPOs) to its credit.
Published:
Last Updated:
Hutchinson China MediTech will offer more than 7 million American depositary shares at $13.50 apiece in and IPO valued at up to more than $116 million.
Published:
Last Updated:
Global Water Resources has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Red Rocks Resorts has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
Aeglea BioTherapeutics has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Senseonics Holdings has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing for...
Published:
Last Updated:
PSAV has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Published:
Last Updated:
Blank-check company KLR Energy Acquisition Corp. (NASDAQ: KLREU) completed its initial public offering (IPO) last Friday, the first successful IPO in the month of March. An Israel-based firm that...
Published:
Last Updated:
Blank-check company KLR Energy Acquisition completed an IPO Friday morning, raising $80 million on the sale of 8 million units at a per unit price of $10.
Published:
Last Updated:
Corvus Pharmaceuticals expects to price more than 4 million shares in the range of $15 to $17 apiece in an initial public offering valued up to nearly $92 million.
Published:
Last Updated:
Audentes Therapeutics has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Published:
Last Updated:
The long-term exit strategy for more than half of U.S. technology and life sciences startups is to be acquired, according to Silicon Valley Bank.
Published:
Last Updated:
Spring Bank Pharmaceuticals expects to price more than 2.8 million shares in the range of $13 to $15 per share in an IPO valued at up to more than $49 million.
Published:
Last Updated:
Wingstop plans to offer more than 5 million shares in a secondary offering valued at up to more than $158 million.
Published:
Last Updated: